US Patent Issued to Amniotics on June 30 for "Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof" (Swedish, Danish Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,593, issued on June 30, was assigned to Amniotics AB (Lund, Sweden).

"Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof" was invented by Jan Talts (Staffanstorp, Sweden), Niels-Bjarne Woods (Furulund, Sweden), Kare Engkilde (Vaerlose, Denmark) and Marcus Larsson (Bjarred, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for purifying, culturing and selecting mesenchymal stem cell (MSC) subpopulations with neonatal quality and adult tissue specificity that are for use in production of advanced therapeutic medicinal products."

The patent was filed on Oct. 16, 2020, under...